What is the anticipated absolute effect of ARB versus placebo on all-cause mortality among CKD class 3b-4?
The anticipated absolute effect of ARB versus placebo on all-cause mortality among CKD class 3b-4 is estimated to be between 32 fewer to 40 more, with a very low quality of evidence due to risk of bias and imprecision.